The Embassy of the United States in Luanda, Angola, is pleased to announce the arrival of 464,090 doses of the Pfizer COVID-19 vaccine that the U.S is sharing with Angola through COVAX. We are sharing these doses not to secure favors or extract concessions. Our vaccines do not come with strings attached. We are doing this with the singular objective of saving lives.
This third batch brings the total number of doses of the Pfizer COVID-19 vaccine provided to Angola by the United States to 1,646,960 (the first and second arrived on August 24 and 26). The batch arrived at the 4 de Fevereiro International Airport in Luanda, via COVAX, today, September 26, at 12:35 pm, this total donation of the vaccines will be the largest by a single country to Angola to fight the COVID-19 pandemic.
To date, the United States has delivered more than 110 million doses of vaccine to more than 60 countries, and it will continue to share vaccine doses as supply becomes available. The United States will purchase and donate an additional 500 million Pfizer vaccine doses for distribution by COVAX through 2022, beyond the 500 million Pfizer vaccine doses we committed in June. That brings our total to over a billion doses donated to the world. The commitment to provide the additional 500 million Pfizer vaccines will continue to fulfill US President Biden’s commitment to strengthen the fight against the global pandemic.
As President Biden has said “the United States is committed to bringing the same urgency to international vaccination efforts that we have demonstrated at home. We are sharing these vaccines to save lives and to lead the world in bringing an end to the pandemic.”
We look forward to continuing coordination with the African Union and Africa’s CDC to deliver these doses across the continent through the COVAX initiative via their established logistical channels.
Distributed by APO Group on behalf of United States Embassy in Angola.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
